The frontotemporal disorders therapy market sales is anticipated to reach a valuation of US$ 451.4 million by the end of 2028, based on the company’s most recent study. With an average annual growth rate of 4.7% through 2028, the frontotemporal disorders therapeutic market research indicates enormous expansion potential. The increasing funding by the governments across …